Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 439-444

  Kim, Ryungsa ^a   Ohi, Yuko ^a   Inoue, Hideki ^a   Toge, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Chemotherapeutic agent; CPP32; Gastric cancer; JNK1

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM TRANSPLANTATION; PACLITAXEL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; STOMACH NEOPLASMS; TAXOIDS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034126231     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kerr JFR, Winterford CM and Harmon BV: Apoptosis: its significance in cancer cancer therapy. Cancer 73: 2013-2026, 1994.
2. Harris CC: Structure and function of the p53 tumor supressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1995.
3. Oren M: Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 5: 221-227, 1994.
4. Reed JC: bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
5. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
6. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson C B: bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
7. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: bad, heterodimeric partner for bcl-XL and bcl-2, displaces bax and promotes cell death. Cell 80: 285-291, 1995.
8. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
9. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Lieberman DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and hax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
10. Salvesen GS and Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 91: 443-446, 1997.
11. Strobel T, Swanson L, Korsmeyer S and Cannistra SA: Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 93: 14094-14099, 1996.
12. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
13. Chirgwin J, Przybyla H, McDonald RA and Rutter W: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
14. Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T and Okada K: Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice. Int J Cancer 50: 760-766, 1992.
15. Geran RI, Greenberg NH, MacDonald MM, Schumacher AM and Abbott BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological system. Cancer Chemother Rep 3: 1-88, 1972.
16. Skulachev VP: Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 423: 275-280, 1998.
17. Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T and Terada M: p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res 51: 5800-5805, 1991.
18. Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J and Rosmarin A: p53 mutations do not predict responses to paclitaxel/radiation for non small cell lung carcinoma. Cancer 78: 1203-1210, 1996.
19. Adler V, Schlaffer A, Kim J, Dolan L and Ronai Z: UV irradiation and heat shock mediate JNK activation via alternative pathways, J Biol Chem 270: 26071-26077, 1995.
20. Chen YR, Meyer C F and Tan TH: Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ-radiation-induced apoptosis. J Biol Chem 271: 631-634, 1996.
21. Yu R, Shtil AA, Tan TH, Roninson IB and Kong ANT: Adriamycin activates c-Jun N-terminal kinase in human leukemia cells: a relevance to apoptosis. Cancer lett 107: 73-81, 1996.
22. Semiya H, Mashima T, Toho M and Tsuruo T: c-Jun NH2-terminal kinase-mediated activation of interleukin-1 β converting emzyme/CED-3-like protease during anticancer drug-induced apoptosis. J Biol Chem 272: 4631-4636, 1997.
23. Lee JM and Bernstein A: Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev 14: 149-161, 1995.
24. Lesoon-Wood LA, Kim WH, Kleinman HK, Weintraub BD and Mixson AJ: Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 6: 395-405, 1995.
25. Kiehntopf M, Brach MA and Hernnann F: Gene therapy in oncology-outlook, benefits and risks. Onkologie 1: 16-26, 1995.
26. Sumantran VN, Ealovega MW, Nunez G, Clarke MF and Wicha MS: Overexpression of Bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55: 2507-2510, 1995.
27. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrisco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T and Cai D: Retrovirus-mediated wild type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991, 1996.